UHRF1 and rheumatoid arthritis: Although further preclinical studies will be needed to develop UHRF1 stabilization as an RA therapeutic strategy, our results provide a basis for investigation of a new therapeutic strategy that has efficacy toward different pathways than those targeted by existing agents, including methotrexate or biologics.